1. Home
  2. List
Reference Patent

Reference - List

  • 310 Hits
  • Search Condition : Filter (MeSH = Caco-2 Cells)
Species Resource Title
Human and Animal Cells COS-7(RCB0539) , CACO-2(RCB0988) , BeWo(RCB1644) Disrupted in renal carcinoma 2 (DIRC2/SLC49A4) is an H+-driven lysosomal pyridoxine exporter.
Human and Animal Cells 293T(RCB2202) , A549(RCB0098) Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis.
Human and Animal Cells CACO-2(RCB0988) Changes in uridine 5'-diphospho-glucuronosyltransferase 1A6 expression by histone deacetylase inhibitor valproic acid.
Human and Animal Cells CAC0-2(RCB0988) , Hep G2(RCB0459) Structure-activity relationships of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine and analogues as inhibitors of acyl-CoA: cholesterol O-acyltransferase.
Human and Animal Cells CACO-2(RCB0988) Eosinophils are the main cellular targets for oral gene delivery using Lactic acid bacteria.
Human and Animal Cells CACO-2(RCB0988) Absorption and Tissue Distribution of Siphonaxanthin from Green Algae.
Human and Animal Cells A549(RCB3677) Bovine lactoferrin increases the poly(I:C)-induced antiviral response in vitro.
Human and Animal Cells CACO-2(RCB0988) Lactose hydrate can increase the transcellular permeability of β-naphthol in rat jejunum and ileum.
Pathogenic bacteria V. parahaemolyticus RIMD2210633 Identification of a Family of Vibrio Type III Secretion System Effectors That Contain a Conserved Serine/Threonine Kinase Domain.
General Microbes JCM2776 , JCM5961 , JCM2952 , JCM3843 , JCM5968 , JCM1471 , JCM1112 , JCM1152 Development of a rapid and sensitive analytical system for Pseudomonas aeruginosa based on reverse transcription quantitative PCR targeting of rRNA molecules.
Human and Animal Cells CACO-2(RCB0988) Modelling the invasion of human small intestinal epithelial-like cells by Salmonella enterica Typhimurium and Listeria monocytogenes using Bayesian inference.
Human and Animal Cells CACO-2(RCB0988) Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis.
Human and Animal Cells CACO-2(RCB0988) Metabolites Produced by a New Lactiplantibacillus plantarum Strain BF1-13 Isolated from Deep Seawater of Izu-Akazawa Protect the Intestinal Epithelial Barrier from the Dysfunction Induced by Hydrogen Peroxide.
Human and Animal Cells Hep G2(RCB1886) Temporary decrease in tacrolimus clearance in cytochrome P450 3A5 non-expressors early after living donor kidney transplantation: Effect of interleukin 6-induced suppression of the cytochrome P450 3A gene.
Human and Animal Cells CACO-2(RCB0988) , 293(RCB1637) MicroRNAs in Apple-Derived Nanoparticles Modulate Intestinal Expression of Organic Anion-Transporting Peptide 2B1/SLCO2B1 in Caco-2 Cells.
Human and Animal Cells CACO-2(RCB0988) Loxoprofen enhances intestinal barrier function via generation of its active metabolite by carbonyl reductase 1 in differentiated Caco-2 cells.
Human and Animal Cells CACO-2(RCB0988) Enhanced water dispersibility and Caco-2 cell monolayer permeability of quercetin by complexation with casein hydrolysate.
Human and Animal Cells CACO-2(RCB0988) Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity.
Human and Animal Cells CACO-2(RCB0988) In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid.
Human and Animal Cells COS-7(RCB0539) , CACO-2(RCB0988) Modulatory Effect of Theaflavins on Apical Sodium-Dependent Bile Acid Transporter (ASBT) Activity.